Jim Simons Asensus Surgical, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.46 - $0.81 $34,763 - $61,214	-75,573 Reduced 58.15%	54,400 $27,000
Q1 2023 May 12, 2023	SELL	$0.36 - $1.0 $8,100 - $22,500	-22,500 Reduced 14.76%	129,973 $86,000
Q4 2022 Feb 13, 2023	BUY	$0.29 - $0.47 $16,326 - $26,461	56,300 Added 58.54%	152,473 $53,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.73 $89,258 - $171,470	-234,891 Reduced 70.95%	96,173 $43,000
Q2 2022 Aug 12, 2022	SELL	$0.37 - $0.61 $391,141 - $644,854	-1,057,138 Reduced 76.15%	331,064 $132,000
Q1 2022 May 13, 2022	SELL	$0.53 - $1.19 $209,169 - $469,644	-394,659 Reduced 22.14%	1,388,202 $870,000
Q4 2021 Feb 11, 2022	BUY	$1.03 - $2.31 $1.84 Million - $4.12 Million	1,782,861 New	1,782,861 $1.98 Million
Q2 2021 Aug 13, 2021	SELL	$1.52 - $3.62 $4.1 Million - $9.78 Million	-2,700,348 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$0.9 - $6.32 $2.43 Million - $17.1 Million	2,700,348 New	2,700,348 $8.78 Million

40.1M

12.4K

Ticker ASXC
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 236,719,008
Market Cap $82.9M
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.